Details of the Drug
General Information of Drug (ID: DM91UKB)
Drug Name |
Tyropanoic acid
|
|||||
---|---|---|---|---|---|---|
Synonyms |
Acidum tyropanoicum; Bilopac; Bilopaque; LS-187166; SCHEMBL2788021; Sodium Tyropanoate (USAN); TYROPANIC ACID; Tyropanoate sodium(USAN; Tyropanoic acid; Tyropanoic acid sodium salt; Tyropaque; WIN 8851-2; tyropanoate; 2-(3-(Butyrylamino)-2,4,6-triiodobenzyl)butanoic acid; 2-(3-(Butyrylamino)-2,4,6-triiodobenzyl)butyric acid; 2-[3-(butyrylamino)-2,4,6-triiodobenzyl]butanoic acid; 27293-82-9; AC1L1KQH; AC1Q4PCM; API0012761; CHEBI:135862; CHEMBL1201261; CTK4F9414; DB09340; DTXSID5048269; EINECS 248-389-8; NSC107434
|
|||||
Structure | ||||||
3D MOL | 2D MOL | |||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 641.02 | ||||
Logarithm of the Partition Coefficient (xlogp) | 4.6 | |||||
Rotatable Bond Count (rotbonds) | 7 | |||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | |||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | |||||
ADMET Property |
|
|||||
Chemical Identifiers |
|
|||||
Cross-matching ID | ||||||
Molecular Interaction Atlas of This Drug
Drug-Metabolizing Enzyme (DME) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||